跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 637 条关于
“QT-019B”
全部
637
临床试验
452
药物
101
机构
1
资讯
83
去年
Qihan Biotech Receives FDA Clearance for QT-019B, First Universal Dual-Target CAR-T Therapy for Refractory Lupus
9个月前
Qihan Biotech Initiates Phase I/IIa Trial of Off-the-Shelf CAR-T Therapy for Refractory Lupus
3个月前
Qihan Biotech Receives FDA IND Clearance for QT-019C Universal CAR-T Therapy Targeting Autoimmune Diseases
去年
LQT-1213 Receives FDA Orphan Drug Designation for Long QT Syndrome Treatment
4个月前
Thryv Therapeutics Initiates Phase 2/3 Trial for Long QT Syndrome Treatment, Receives FDA Fast Track Designation
7个月前
QT Sense Secures €4M to Advance Quantum Nanodiamond Platform for Real-Time Cellular Drug Discovery
去年
Thryv Therapeutics Unveils Breakthrough SGK1 Inhibitor Data for Heart Failure and Long QT Syndrome at ESC Congress 2025
去年
Syndax's Revuforj (revumenib) Receives FDA Approval for KM2A-Rearranged Leukemia
2年前
FDA Finalizes Guidance on Clinical Pharmacology Considerations for Antibody-Drug Conjugates
去年
Adjuvant Ribociclib Approved for HR+/HER2- Early Breast Cancer, Offering New Hope for High-Risk Patients
第 1 页,共 9 页
上一页
下一页